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Infection imagingAbstract Amoxicillin, a penicillin derivative was synthesized as ready-to-used single vial kit and
radiolabeled with technetium-99m. Various trials have been carried out to optimize the concentra-
tion of stannous chloride, amoxicillin, pH and reaction time. Radiochemical purity, in vitro and
in vivo stability, partition co-efﬁcient, protein binding and biodistribution in rabbit infected
with Streptococcus pneumoniae were studied. The biodistribution studies in rabbit showed
that 99mTc-amoxicillin started to accumulate in the infected area at 1-h postadministration.
99mTc-amoxicillin may prove itself as potential novel radiopharmaceutical for imaging infections
caused by many bacteria.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2. Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.1. Labeling procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.2. Radiochemical analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.3. Stability tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.4. Partition coefﬁcient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.5. Protein binding. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00y (2015),
2 S.K. Shahzadi et al.2.6. In vitro binding of 99mTc-amoxicillin with bacteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.7. Biodistribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3. Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.1. Effect of stannous chloride concentration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.2. Effect of amoxicillin concentration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.3. Effect of pH. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.4. Effect of reaction time. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.5. Stability tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.6. Protein binding and partition co-efﬁcient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.7. In vitro binding of 99mTc-amoxicillin to bacteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.8. Biodistribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
4. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 001. Introduction
In developing countries where the environment is not fully
hygienic, microbial actions are causing several infectious dis-
eases associated with morbidity. So the identiﬁcation of infec-
tion site at primary stage of the disease is crucial for successful
treatment. The risk factors of morbidity that were associated
with infectious diseases sharply decreased after the develop-
ment of radiopharmaceuticals (Naqvi et al., 2012).
Now there is a wide range of antimicrobial agents that are
being radiolabeled. The ﬁrst group includes radiolabeled
antibiotics such as 18F or 99mTc-ciproﬂoxacin (Britton et al.,
2001; Hall et al., 1996; Sarda et al., 2002, 2003; Siaens et al.,
2004; Langer et al., 2005), 99mTc-sparﬂoxacin (Singh et al.,
2003), 99mTc-ceftizoxime (Martin-Comin et al., 2004; Gomes
et al., 2005) and 18F-ﬂeroxacin (Fischman et al., 1992). The
second group of infection imaging agents is derived from
human anti-microbial peptides/proteins that have afﬁnity to
bind to speciﬁc bacterial antigens (Lupetti et al., 2003a,b),
e.g. peptides (derived from human lactoferrin) (Welling
et al., 2001), ubiquicidin labeled with 99mTc or 18F (Lupetti
et al., 2003a,b; Nibbering et al., 1998; Mele´ndez-Alafort
et al., 2004; Akhtar et al., 2004; Welling et al., 2000; Zijlstra
et al., 2006) and 99mTc-human neutrophil peptide 1–3
(Welling et al., 1999). The third group consists of vitamins
and bacterial growth factors, such as vitamin H, a group B
vitamin (biotin) labeled with 111In (Lazzeri et al., 2008).
Use of radiolabeled antibiotics is rapidly becoming an aus-
picious diagnostic test for the detection of infectious lesions
because of its speciﬁc binding to bacterial components
(Singh and Bhatnagar, 2010). The ﬁrst clinical application of
99mTc-ciproﬂoxacin was performed by Vinjamuri et al. (1996)
and the capacity of 99mTc imaging was compared with
radiolabeled WBCs imaging to assess the bacterial infection
(Vinjamuri et al., 1996). Most other ﬂuoroquinolone
antibiotics, cephalosporin and some other antibacterial
agents were radiolabeled and used for imaging bacterial
infections with promising results. Penicillin has been found
to be more effective in several types of intracellular infections,
including those caused by Helicobacter, Streptococcus,
Bacillus subtilis, Haemophilus, Enterococcus and Moraxella
(Amoxicillin Susceptibility and Resistance Data Retrieved 20
July 2013).Please cite this article in press as: Shahzadi, S.K. et al., 99mTc-amoxicillin: A novel ra
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beled and studied as radiopharmaceutical in the presented
work. The data obtained about the labeling of 99mTc with
amoxicillin and its in vivo study are preliminary. Extensive
research is required to investigate more efﬁcient labeling con-
ditions to label amoxicillin with 99mTc. Also, some systematic
experimentation is required to study the complete proﬁle of
efﬁcacy and pharmacokinetics of 99mTc-amoxicillin against a
variety of gram-negative and gram-positive bacteria.
The objective of presented study was to develop
99mTc-amoxicillin into a single vial kit to identify bacterial
infection in experimental model of Streptococcus pneumoniae
induced infectious lesion in a rabbit.
2. Materials and methods
Amoxicillin was donated by Java pharmaceutical; Lahore,
Pakistan. 0.22 lm ﬁlters from MS Nylon Membrane
Filters, USA were used. 99mTc was eluted as 99mTcO4
 from
99Mo/99mTc generator, PINSTECH, Islamabad, Pakistan.
Radioactivity measurements were performed using Well-type
NaI(Tl) gamma(c)counter. All chemicals that were used in
the research were of analytical grade and were used without
further puriﬁcations. Rabbits were obtained from animal
house, INMOL, Pakistan. All animal experiments were per-
formed after the approval of Animal Ethical Committee of
the institute.
2.1. Labeling procedure
Optimization studies were performed to ﬁnd out the best con-
ditions for the labeling of amoxicillin with technetium.
Labeling efﬁciency was analyzed by varying stannous chloride
concentration from 25 to 300 lg, amoxicillin concentration
from 0.5 to 3 mg, pH from 3 to 7 and reaction time from 5
to 60 min. All the tests were performed in triplicates (n= 3).
To formulate the amoxicillin kit, 2.0 mg amoxicillin, 2.0 mg
gentisic acid, 20 mg D-mannitol and 3.0 mg D-Penicillamine
(co-ligand) were dissolved in 1 ml distilled water under contin-
uous stirring (Solution A). Then stannous chloride, 50 lg
(1 ml) from a solution having 50 lg SnCl2Æ2H2O and 5 mg
Sodium/Potassium pyrophosphate in 1 ml distilled water,
was added drop by drop to solution A. The pH was set at 5diopharmaceutical for infection imaging. Arabian Journal of Chemistry (2015),
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by a (0.22 lm) ﬁlter. All experiments were performed at room
temperature (30 ± 2 C). Kits of amoxicillin were prepared,
lyophilized and stored at 4 C. Kit’s preparation was per-
formed under sterile conditions in a laminar ﬂow hood at
room temperature. Freshly eluted sodium pertechnetate
(370 MBq) obtained from in-house pakgen99mTc-generator,
was added to freeze dried kits and incubated at room
temperature.
2.2. Radiochemical analysis
Radiochemical analysis of 99mTc-amoxicillin was performed
by Instant thin layer chromatography and paper chro-
matography. Paper chromatography was employed to deter-
mine the percentage of free pertechnetate (99mTcO4
). A
strip of Whatman 3 MM chromatographic paper was
marked 1 cm from above and below side with lead pencil.
A drop of sample kit was spotted on the Whatman paper
using 25 gauge (1 ml) insulin syringe and was placed into a
sample vial containing acetone as a mobile phase. After the
solvent has reached the front line, strip was removed and
dried. Strip was cut into two equal pieces and their
radioactivity was measured using well-type NaI(Tl)
gamma(c)counter.
To determine the %age of reduced/hydrolyzed technetium
(99mTcO2), ITLC was employed. A strip of ITLC (6 cm · 1 cm)
was marked 1 cm above from bottom with lead pencil. A 25
gauge (1 ml) insulin syringe was used to spot the drop at the
paper strip. After that, paper strip was placed in a sample vial
containing saline (0.9% NaOH) as a mobile phase. After the
solvent reached the front line, strip was removed and dried.
The strip was cut into two equal pieces and radioactivity of
each piece was measured by using well-type NaI(Tl)
gamma(c)counter.
Percentage of labeled complex is calculated by subtracting
the sum of 99mTcO2 and
99mTcO4
 from hundred.
2.3. Stability tests
The stability 99mTc-amoxicillin complex at room temperature
was studied to detect any dissociation of the complex and to
determine suitable time for the injection of complex to avoid
formation of undesired product which resulted from radiolysis
of labeled complex. This undesired radioactive product may
accumulate in nontarget organs.
For this purpose, 99mTc-amoxicillin was kept at room tem-
perature for 1–6 h. Radiochemical purity was checked after
each hour by paper chromatography and ITLC to ﬁnd any sig-
niﬁcant loss in labeling efﬁciency.
In vitro stability of 99mTc-amoxicillin complex in blood
serum was also checked to detect any degradation of the
complex by blood serum enzymes. For this purpose, 5 ml
blood was taken and centrifuged at 3000 rpm for 10 min.
Blood serum was separated from blood cells. 1.8 ml of
serum was taken out in a sample vial and 0.2 ml of
99mTc-amoxicillin kit was added in it. Sample vial was incu-
bated at 37 C. Radiochemical purity of the labeled kit was
checked for different time intervals (1–6 h) by using paper
chromatography and instant thin layer chromatography
(ITLC).Please cite this article in press as: Shahzadi, S.K. et al., 99mTc-amoxicillin: A novel ra
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In order to calculate partition coefﬁcient, octanol/saline was
used as organic and inorganic layer. Counts in 100 ll of both
layers were calculated with well-type NaI(TI) c-counter.
Partition coefﬁcient value is calculated by Eq. (1) (mean ±
SD, n= 3).
Log P Value : Log ð% in octanol=% in salineÞ ð1Þ2.5. Protein binding
Protein binding of the labeled complex was measured by incu-
bating it with fresh human blood for 1 h, placing it in a pre-set
water bath (37 C) for 10 min, centrifuging at 3000 rpm,
including equal volume of 10% ‘‘Trichloroacetic acid’’
(TCA) and centrifuging again. Afterward both supernatant
and residue were counted for radioactivity.
2.6. In vitro binding of 99mTc-amoxicillin with bacteria
To study the binding assay of 99mTc-amoxicillin with bacteria,
in vitro studies were performed. Approximately 3 ml of bacte-
rial culture (S. pneumoniae) was centrifuged for 10 min.
Supernatant was separated from pellet and was poured into
a sterile sample vial. Pellet was resuspended into 1.5 ml of
acetic acid (0.2 M) and 1.5 ml of sodium phosphate buffer
(0.2 M). 0.8 ml of resulting solution was taken into three dif-
ferent tubes and 0.1 ml of sodium phosphate buffer was added
into each tube. 10 lg, 50 lg and 100 lg of 99mTc-amoxicillin
were added into each tube and incubated at 4 C for 1 h.
After incubation, all the tubes were centrifuged for 5 min.
Supernatant was separated into a separate tube and pellet
was suspended into 1 ml sodium phosphate buffer and was
centrifuged for 5 min. Radioactivity measurements were taken
separately for both supernatant and pellet by using well type
gamma ray counter. Percent binding of given complex with
bacteria was found by Eq. (2) as follows:
% Binding to Bacteria¼Counts in Pellet=ðCounts in Supernatant
þCounts in PelletÞ 100
ð2Þ2.7. Biodistribution
For normal biodistribution studies, 500 ll (74 MBq) of 99mTc-
amoxicillin was injected in the iliac vein of rabbit after valium
(1.0 ml) anesthesia. Scintigraphic images were taken at 1 h and
2 h postinjection with Inﬁnia dual head gamma camera.
For biodistribution study in infected rabbit, 1.0 ml suspen-
sion (3 · 108 CFU/ml) of S. pneumoniae was injected in rabbit
(thigh muscles). After the initiation of swelling at the infected
site of rabbit, 500 ll (74 MBq) of 99mTc-amoxicillin was
injected. Scintigraphic images were taken at 1 h, 2 h and 24 h
postinjection with Inﬁnia dual head gamma camera.
3. Results and discussion
Various electron donor species are present in amoxicillin struc-
ture e.g. oxygen, nitrogen and sulfur (Fig. 1a). 99mTc candiopharmaceutical for infection imaging. Arabian Journal of Chemistry (2015),
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Figure 1b Proposed structure of 99mTc-amoxicillin complex.
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Figure 2 Effect of stannous chloride concentration on labeling
yield of 99mTc-amoxicillin complex.
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Figure 3 Effect of amoxicillin concentration on labeling yield
99mTc-amoxicillin complex.
4 S.K. Shahzadi et al.interact and form complex with these electron donor atoms.
Also, D-Penicillamine can provide additional electron donating
atoms for transchelation. Although exact structure of 99mTc-
amoxicillin is unknown, proposed structure of this complex
is given in Fig. 1b.
Optimization of labeling conditions revealed that highest
labeling efﬁciency was achieved when 50 lg stannous chloride,
and 2 mg amoxicillin was labeled with sodium pertechnetate
(370 MBq) at pH 5 and incubation time of 30 min. The reac-
tion is favorable at little acidic pH but by shifting toward basic
pH, labeling efﬁciency decreased. At these conditions, maxi-
mum labeling yield was >98%. In ITLC, saline was used as
solvent, very small activity remained at origin corresponding
to reduced 99mTc. In paper chromatography, acetones were
used as solvent, and small amount of the activity was moved
which was belonged to free 99mTcO4
.
3.1. Effect of stannous chloride concentration
Stannous chloride is commonly used as reducing agent for the
reduction of pertechnetate, which favors its chelation with
amoxicillin. Fig. 2 illustrates the variation of labeling efﬁ-
ciency, free 99mTcO4
 and the reduced/hydrolyzed 99mTcO2
with changing concentration of reducing agent.
Stannous chloride concentration has strong effect on label-
ing yield, amount of free pertechnetate and colloidal form.
With the increase in stannous chloride concentration, labeling
yield was observed to increase with the corresponding decrease
in percentage of free pertechnetate and colloidal form. At
50 lg, labeling efﬁciency was found to increase to about
98%. It was the lowest amount of stannous chloride that
reduced the maximum amount of 99mTcO4
, hence offered
maximum labeling yield. When the concentration of stannous
chloride was increased above 300 lg, amount of colloidal form
was observed to increase to a larger extent with corresponding
decrease in labeling efﬁciency.Please cite this article in press as: Shahzadi, S.K. et al., 99mTc-amoxicillin: A novel ra
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Concentration of amoxicillin was varied from 0.5 mg to 3 mg
and labeling efﬁciency was checked at each concentration to
optimize the minimum amount of amoxicillin that will give
the maximum labeling. Fig. 3 clearly depicts the effect of
amoxicillin concentration on labeling yield, amount of free
99mTcO4
 and reduced/hydrolyzed (99mTcO2) form. By increas-
ing amoxicillin concentration, labeling yield was found to
increase up to 2 mg of amoxicillin. By further increasing the
amoxicillin amount, there was no signiﬁcant increase in label-
ing yield or decrease in level of free 99mTcO4
 and reduced/
hydrolyzed (99mTcO2) form. After addition of 2 mg concentration
of amoxicillin, labeling yield and amount of free 99mTcO4
 and
reduced/hydrolyzed (99mTcO2) form become almost constant.
It depicted that 2 mg concentration of amoxicillin is best for
maximum labeling yield.
3.3. Effect of pH
Labeling yield was affected by changing pH of the reaction
mixture. At low pH, labeling yield was poor. By increasing
pH, labeling yield also increased till pH 5. After pH 5, labeling
efﬁciency started decreasing with corresponding increase in
amount of free 99mTcO4
 and reduced/hydrolyzed (99mTcO2)
(Fig. 4).
3.4. Effect of reaction time
Reaction time represents the minimum time required to label
the complex. The maximum yield was achieved at 30 min.
After 30 min, it reached to its saturation value i.e. by increas-
ing time, labeling yield remained almost constant (Fig. 5).diopharmaceutical for infection imaging. Arabian Journal of Chemistry (2015),
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Figure 8 Biodistribution in normal rabbit at 1-h and 2-h
postinjection of 99mTc-amoxicillin.
Figure 9 Biodistribution in infected rabbit at 1-h, 2-h and 24-h
postinjection of 99mTc-amoxicillin.
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In vitro stability tests at room temperature and in human
serum at 37 C showed stability for 6 h (Fig. 6). The complex
showed no signiﬁcant disintegration till 6 h. It means that there
was no colloidal impurity and instability.
3.6. Protein binding and partition co-efﬁcient
99mTc-amoxicillin complex showed high binding with proteins.
Almost 76 ± 5% of 99mTc-amoxicillin complex showed pro-
tein binding while 24 ± 5% of it remained unbound.
Partition coefﬁcient test was conducted to ﬁnd the nature of
the complex i.e. it was either lipophilic or hydrophilic. High
log P value showed that the 99mTc-amoxicillin complex was
highly lipophilic.
3.7. In vitro binding of 99mTc-amoxicillin to bacteria
In vitro binding of 99mTc-amoxicillin complex with S. pneumoniae
showed that binding of 99mTc-amoxicillin with bacteria was
highly dependent on incubation time and concentration
(Fig. 7).Please cite this article in press as: Shahzadi, S.K. et al., 99mTc-amoxicillin: A novel ra
http://dx.doi.org/10.1016/j.arabjc.2015.04.003After ﬁrst hour of incubation, binding of 99mTc-amoxicillin
with S. pneumoniae was 3.5% at 100 lg concentration which
was very low, but after 2 h, its binding was increased and
was found to be 60% at 50 lg concentration.
3.8. Biodistribution
In normal biodistribution studies, at ﬁrst hour radio-ligand
was accumulated in the liver, and spleen but cleared rapidly
after 2 h, so excretion is time dependent as shown in scinti-
graphic images (Fig. 8). Biodistribution in normal rabbit
showed higher value of activity in kidney and bladder and it
is suggested that 99mTc-amoxicillin is excreted mainly through
this pathway.diopharmaceutical for infection imaging. Arabian Journal of Chemistry (2015),
Table 1 Bio-distribution of 99mTc-amoxicillin in Streptococ-
cus pneumoniae infected rabbit (% ID/g ± SD, n= 3).
Organ 1 h 2 h 24 h
Thigh (target) 1.92 ± 0.08 2.24 ± 0.09 0.89 ± 0.06
Thigh (non-target) 0.54 ± 0.08 0.48 ± 0.01 0.39 ± 0.02
Kidneys (LT) 1.43 ± 1.10 1.57 ± 1.20 1.22 ± 1.23
Kidneys (RT) 2.06 ± 1.40 1.70 ± 1.23 1.44 ± 1.4
Liver 2.09 ± 1.21 1.83 ± 1.23 1.89 ± 1.26
Urinary bladder 52.11 ± 1.2 63.78 ± 1.24 63.82 ± 1.27
6 S.K. Shahzadi et al.In-vivo binding with S. pneumoniae showed encouraging
results (Fig. 9). Scintigraphic data also explained that 1 h
postinjection is the minimum time suitable for scanning of
infection.
The excretion of the radioactivity from organs is fast and
there was no accumulation in any organs and after 24 h some
of its quantity was observed at infection site and urinary blad-
der (Table 1).
4. Conclusion
In present work amoxicillin kits were prepared, and
radio-labeled with 99mTc and labeling yield was (<95%).
99mTc-amoxicillin complex was found to be stable at room
temperature and also in human blood serum at 37 C for
6 h. The radio-labeled kits showed good binding efﬁciency
both in in vitro and in vivo studies against S. pneumoniae.
The complex showed high uptake in infected thigh muscle
within 1 h postinjection so it is suggested best suitable time
for the imaging of infection. These promising characteristics
of 99mTc-amoxicillin make it a suitable candidate for imaging
infection foci against a variety of bacteria.
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